Episode Details
Back to Episodes
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
Season 25
Episode 66
Published 2 weeks ago
Description
Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.
CME information and select publications here.